Connection
Hitoshi Irabu to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Hitoshi Irabu has written about Immunoglobulins, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.087 |
|
|
|
-
Shimizu M, Irabu H, Shimbo A, Kaneko S, Mori M. Monthly intravenous immunoglobulin for refractory intestinal IgA vasculitis. Pediatr Int. 2023 01; 65(1):e15470.
Score: 0.045
-
Yamaguchi Y, Takasawa K, Irabu H, Hiratoko K, Ichigi Y, Hirata K, Tamura Y, Murakoshi M, Yamashita M, Nakatani H, Shimoda M, Ishii T, Udagawa T, Shimizu M, Kanegane H, Morio T. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child. J Infect Chemother. 2022 Jun; 28(6):814-818.
Score: 0.042